Luker, here are the differences with zero bias.
TRXC SURGIBOT
-costs $500,000, instruments for each procedure around $1,000
-has HD 3D vision where surgeons and bed time assistants wear 3D glasses. This is so everyone operating and assisting on patient is seeing exact same thing and no confusion (where as other consoles only surgeon sees in 3D so when he directs bedside assistant they're not seeing the same thing
-surgeon is standing scrubbed in next to the patient. The surgeon controls two arms that are computer and motor assisted and control tools inside patient. They can reposition arm and lock it in place, and have plenty of scaling options. (The surgeons hands are actually on the tools inside the patient! but they have assistance from motor and computer for much better strength, dexterity)
-the above point allows the surgeon to have 100% tactile feedback. Lack of tactile feedback is the reason behind countless deaths and lawsuits for ISRGs da Vinci system
-TRXC has advanced energy device that produces ZERO smoke, the first of it's kind!!! (That's a $2 billion industry alone)
-TRXC has been backed by 6+ venture capitalists since it's inception in mid 2000s, also has two prominent billionaires who own 10% each of the company and has outstanding track record (Phil frost and dr. Jane Hsaio)
--improved strength, dexterity, ergonomics of device compared to their last FDA approved surgical device, which is being utilized by more than 6 prominent gold star rated surgeons, including a huge advocate of the technology, dr Michael Geigner who is the father of minimally invasive surgery
-install base of 200+ hospitals/surgeons already using TransEnterix technology
-TINY share float, a real low float monster once good news comes
-device will be approved by FDA in Q1, and begin commercialization in US and Europe beginning in Q3 2015.
- tiny foot print and very mobile, a breeze to move from different OR rooms
-small tiny 25 mm incision
-internal triangulation
-fully funded for commercial launch
-trading on major exchange (NYSE), being added to the Russell index next Friday
TITAn MEDICAL SPORT
Very similar to ISRG system
-surgeon is 10 feet away from patient sitting down staring into console
-zero tactile feedback, surgeon can only rely on his sight and does not feel any tension or vibrations with instruments
-tiny 25mm incision
-tiny foot print/mobile
-fully funded for commercialization
-3d vision only for doctor who is hunched over looking into screen. Bedside assistants do not see the same thing the doctor is seeing, can lead to accidents
-run over computer wires because of distance from patient, same for ISRG and has lead to system shutdowns in middle of surgery
-costs $800,000 ($300,000 more than TRXCs, which is big difference for small hospitals being targeted)
-no venture capitalists
-begin selling middle of 2016
Basically the big difference is price, TRXC being more affordable, and fact that surgeon can actually feel 100% tactile feedback (leads to very quick training, about one hour for surgeons already trained for traditional, non robotic surgery.
Surgeon is also patient side and right next to them throughout whole surgery when compared to TITXF system.
3d for all assistants and surgeon is much better than only surgeon seeing in 3d also
Price and true tractile feedback means TRXC will have a much easier time selling device
